Archives

by in
Entry Author Date Location
Genzyme Annual Meeting Remarkably Mundane, Despite Rocky Year 06/16/10 Boston
Polaris Raises $234M for New Fund, BioScale Pins Down $25M, Clinical Data Nets $30M, & More Boston-Area Deals News 06/16/10 Boston
Genzyme Borrows $1B for Stock Buyback 06/15/10 Boston
Modumetal Closes Series B, TerraPower Pulls In $35M, Vertafore Bought for $1.4B, & More Seattle-Area Deals News 06/15/10 Seattle
Motricity, Riding the Mobile Software Wave, Primed for $85M IPO This Week 06/14/10 Seattle
Biogen CEO Retires, Genzyme Board Nominates Amgen Vet and Strikes Deal with Icahn, Xconomy Spotlights Life Sciences XSITE Speakers, & More Boston-Area Life Sciences News 06/11/10 Boston
Genzyme Cuts Deal With Carl Icahn on Eve of Shareholder Vote 06/09/10 Boston
Biogen’s CEO Retires Tomorrow, COO to Follow 06/07/10 Boston
Genzyme Taps Amgen Vet for Board 06/07/10 Boston
Oxford’s Fambrough Leaves for Dicerna, Clinical Data Aims to Take on Big Pharma with Antidepressants, Genzyme’s Termeer Courts Shareholders, & More Boston-Area Life Sciences News 05/14/10 Boston
Genzyme in “Tough Spot” with Icahn Proxy Challenge—CEO Termeer Courting Key Shareholders 05/13/10 Boston
Icahn Blasts Genzyme Manufacturing, Glaxo Halts “Red Wine” Drug Trial, Ariad Gets $69M from Merck, & More Boston-Area Life Sciences News 05/07/10 Boston
$2B Stock Buyback for Genzyme 05/06/10 Boston
Icahn Calls Genzyme’s Manufacturing “Broken,” Advises Against Termeer’s Re-Election to Board 05/04/10 Boston
Genzyme Activist Joins Board, Agios Clinches Deal With Celgene, Third Rock Seeks $400M New Fund, & More Boston-Area Life Sciences News 04/16/10 Boston
Genzyme Adds Whitworth to Board, WSJ Says 04/14/10 Boston
Biogen Idec Reaches Deal With Icahn, Ironwood CEO Shares IPO Strategy, Luke Maps out the Genetics Institute Diaspora, & More Boston-Area Life Sciences News 03/26/10 Boston
Icahn Gets One More Seat on Biogen Board 03/22/10 Boston
Biogen Idec Seeks Science-Savvy CEO, LifeImage Partners With EMC, GenomeQuest Aims to be Genetic Google, & More Boston-Area Life Sciences News 02/26/10 Boston
Icahn Making His Move On Genzyme 02/22/10 Boston
Chairman Bill Young: Next Biogen Idec CEO May Be a Scientist 02/22/10 Boston
Sirtris Founders Resurface with New Fund, Icahn Continues to Make Biotech Waves, Sentillion Bought by Microsoft, & More Boston-Area Life Sciences News 02/19/10 Boston
Icahn Boosts Genzyme Stake 02/16/10 Boston
Carl Icahn Nominates Scripps Researcher to Biogen Idec Board, BrainCells Pursues New Drug Combo for Depression, Illumina Adds to Oxford Nanopore Investment, & More San Diego Life Sciences News 02/04/10 San Diego
All Eyes On Ironwood IPO, Icahn Seeks Biogen Board Seats, Boston Scientific Settles with J&J, & More Boston-Area Life Sciences News 02/03/10 Boston
Carl Icahn Nominates Three More Candidates for Biogen Board Seats 01/28/10 Boston
Motricity Files for IPO 01/22/10 Seattle
6 Goals for Fixing Genzyme: Xconomy’s Q&A With Relational Investors’ Ralph Whitworth 01/21/10 San Diego
Agreement Between Genzyme and San Diego Activist Shareholder Suggests Truce 01/07/10 San Diego
Biogen Idec CEO Stepping Down, Ambrx Focuses on Empowered Antibodies, Intellikine Testing First Drug Candidate, & More San Diego Life Sciences News 01/07/10 San Diego
Page 2 of 6 « previous page · next page »